ACE Inhibitor Pharmacokinetics
From Proteopedia
ACE-Inhibitor Pharmacokinetics Comparison at Equivalent Dosages | |||||||
---|---|---|---|---|---|---|---|
Parameter | Captopril | Lisinopril | Ramipril | Enalapril | Benazepril | Perindopril | Trandolapril |
Tmax (hr) | .98 | 6.5 | .67 | 1.06 | .5 | .75 | .72 |
Cmax (ng/ml) | 1210 | 79 | 16.4 | 314 | 149 | 105 | 1.68 |
Bioavailability (%) | 72 | 25 | 28 | 60 | 97 | 24 | 10 |
Protein Binding (%) | 97 | 0 | 73 | 20 | 97 | 20 | 80 |
T1/2 (hr) | .56 | 10.1 | 1.93 | 1.6 | 10 | .9 | .68 |
AUC (ng/ml/hr) | 1673 | 1016 | 21.9 | 450 | 140 | 182 | 1.86 |
IC50 (nM) | 1.1 | 5.5 | 5.0 | 5.4 | 1.7 | 2.4 | 2.5 |
Dosage (mg) | 10 | 20 | 5 | 20 | 10 | 4 | 2 |
Metabolism | Hepatic (CYP2D6) | None | Hepatic | Hepatic (CYP3A4) | Hepatic | Hepatic | Hepatic (CYP2D6 & CYP2C9) |
For Pharmacokinetic Data References, See: References